2. IMMUNIZATION
⢠Immunisation is the process by which
acquired immunity is induced.
Acquired Immunity
⢠Protection from disease
⢠Provided by introduction antigens or
premade antibodies into the body
3. Acquired Immunity
Active immunity
⢠In response to stimulus by an
antigen characterized by the
production of antibodies by the
host.
Passive immunity
⢠Immunity transferred in ready
made form.ie,no role of
immunesystem of the recipient.
4. Active immunity
Naturally acquired
⢠Repeated clinical &
subclinical infection
in childhood give
immunity.
⢠Eg:chicken pox
Artificially acquired
⢠Immunity induced
by vaccination
5. Passive immunity
Naturally acquired
⢠Transfer of maternal
antibodies
⢠Eg:
â Through placenta=Ig G
â Through colostrum=Ig A
Artificially acquired
⢠Following
administration of
Immune globulin or
antiserum
⢠Eg:Anti tetanus
serum(ATS)
7. VACCINATION
⢠A vaccine is an immuno-biological
substance(Ag) designed to produce specific
protection against a given disease.
⢠A vaccine is âantigenicâ but not âpathogenicâ.
8. Types of vaccines
⢠Attenuated live vaccines
⢠Inactivated killed vaccines
⢠Toxoids
⢠Polysaccharide and polypeptide (cellular fraction) vaccines
⢠Surface antigen (recombinant) vaccines.
9. Live Vaccines
Advantages
⢠Single dose enough
⢠Produce local immunity
⢠lnduce cell mediated immunity
⢠More convenient for mass immunization
Disadvantages
⢠Reversion to virulence
⢠Difficulty in storage
10. Killed Vaccines
Advantages
⢠No danger of spread
⢠Stability and safety
Disadvantages
⢠Multiple injection may be required
⢠May be contaminated with
⢠dangerous infectious agent
13. VACCINE ADVERSE REACTIONS
⢠Local
â Pain, swelling, redness at site of injection
â Common with inactivated vaccines
â Usually mild and self-limited
⢠Systemic
â Fever, malaise, headache
â Nonspecific
â May be unrelated to vaccine
⢠Allergic
â Due to vaccine or vaccine component
â Rare
14. VACCINE COLD CHAIN
⢠The system of transporting, storing and distributing vaccines in
a potent state at the recommended temperature from the
point of manufacture to the point of use is the Cold Chain.
⢠Vaccine potency once lost cannot be restored.
17. ⢠Whole cell vaccine
âContains suspension of whole bacterial cells
that have been killed. Eg: DTwP
âMore effective but less safe
⢠Acellular vaccine
âCell free vaccine prepared from purified
antigenic component of cell free
microorganism.
âie,doesnot have complete cell but contains
fragments of cell best suited to stimulate
immune response. Eg: DTaP
âLess effective than DTwP but more safe
18. Vaccine Failure
⢠Primary = administration of recommended dose of vaccine
doesnot result in adequate protection against disease.
⢠Secondary = disease occur inspite of immunsiation.
20. BCG VACCINE
⢠Live attenuated vaccine (Bacille Calmettee â Guerin
strain)
⢠Dose: 0.05ml in neonates & 0.1ml in others
⢠Intradermal injection in to left hand on deltoid area.
⢠Controls hematogenous spread thus preventing Miliary
TB, Disseminated TB, TB Meningo encephalitis(80%)
⢠Reconstitute with 1 ml of Sodium Chloride Inj. IP.
⢠Complications:ulceration ,lymphadenitis...
⢠C.I ---immunocompromised
21. Oral Polio Vaccine
⢠OPV â Live attenuated Polio virus
â Type I - Type II - Type III
⢠Dose â 2 drops oral at birth,6,10, 14 weeks, 16-24 months
⢠Contraindication-in immunocompromised, diarrhea, infectious
fever
⢠MgCl2 is the stablizing agent
⢠Pulse polio immunization -- giving 2 doses 1month apart
⢠Complications: Vaccine associated paralytic polio--VAPP (due to
type 2)
22. Injectable Polio Vaccine
⢠Formaldehyde killed and purified poilio virus
â Type I-40
â Type II-8 D antigen units
â Type III-32
⢠Immunity â humoral, local pharyngeal,
intestinal
⢠Safe
⢠6,10,14 weeks according to IAP
23. DTwP / DTaP vaccines
⢠DTaP has been licensed in India for private use
⢠Current recommendations for use of DTaP
â For infants who had severe reaction to 1st dose of DTwP
â For adolescents and adults
â For infant immunized abroad with DTaP
⢠DTaP adult formulation has now been recommended as booster by
WHO for adolescents and adults.
⢠Absolute contra indications for DTwP
â Anaphylaxis to previous dose
â Progressive neurological disorder
â Hypotensive hyporesponsive episodes
24. MEASLES VACCINE
⢠Live attenuated vaccine (Edmonston-Zagreb strain)
⢠Given IM or SC
⢠Given at 9 months (because at that time maternal antibody
wean off)
⢠Contraindications
â Malignancy
â Therapy with alkylating agent/ corticosteroid
â Immune deficiency
⢠Side effect -- TSS (toxic shock syndrome) due to bacterial
contamination.
25. MMR vaccine
⢠Measles---Edmonston-Zagreb strain
⢠Mumps-Jeryl Lynn strain
⢠Rubell--RA 27/3 strain
⢠Dose is 0.5 ml (2 dose one at 15 month and another 8 weeks later)
(S / C).
⢠Contraindication--pregnancy,immunosuppression
26. HEPATITIS B VACCINE
⢠Recombinant DNA vaccine (in yeast)
⢠0.5 mL IM in <1 year and 1 mL > 1 year
⢠3 doses at 0, 1, 6 months
⢠HBIG gives passive immunity
⢠HBIG should be given preferably within 48 hours of exposure.
27. TYPHOID VACCINE
⢠2 doses
⢠0.5 mL SC 1 month interval (killed vaccine)
⢠Typhoral-- oral live vaccine (stable mutant S. typhi strain type 2
Ia)
⢠Typhim-- give SC or IM single dose
28. Hib VACCINE
⢠Capsular polysaccharide used as antigen
⢠Given particularly prior to splenectomy
⢠3 dose below six months
⢠2 dose between 6-12 months
⢠1 dose between 12-15 months
⢠And a booster dose should be in this children at
18 months
⢠>15 months--only one dose
29. HPV Vaccine
⢠0.5 mL IM deltoid
⢠Recommended age for initiation of vaccine is
10-12 years
⢠3 doses at 0,2,6 months
30. Chickenpox Vaccine
⢠Dose--0.5 mL S /C or IM 2 doses 4-8 weeks apart >13
years
Pentavalent vaccine
⢠Trail in Kerala,Tamil Nadu
⢠Contains D , P , T , Hib , Hep B.
⢠Schedule-6,10, 14 week
31. National Immunization Schedule
Age Vaccines
Birth BCG, OPV0 (for institutional deliveries)
6 weeks DTwP1, OPV1, HepB1, Hib1$$ (BCG if not
given at birth)
10 weeks DTwP2, OPV2, HepB2, Hib2
14 weeks DTwP3, POV3, HepB3, Hib3
9-12 months Measles
16-24 months DTwP B1, OPV4, MMR
5-6 years DTwP
10 years TT
16 years TT
Pregnant women TT1 (early in pregnancy)
TT2 (1 month later)
TT booster (if vaccinated in past 3 years)
32. IAP recommended vaccines for
routine use
Vaccines under special
circumstances
BCG,
OPV
IPV
DTwP/DTaP
DT
Td
Tdap
Measles
Typhoid
Hib
Hep B
MMR
HPV
PCV
Hepatitis A
Chicken Pox
Rotavirus vaccine
Rabies
Influenza
PPSV23
Japanese Encephalitis
Meningococcal
Cholera
Yellow Fever
35. 18 months Hepatitis A 2
2 years Typhoid 1
5 years DTwP B2 / DTaP B2
OPV5
MMR2
Typhoid 2
Varicella 2
10 to 12 years Tdap/Td
HPV^
36. vaccination schedule for an unimmunized child
Visit Suggested vaccines
First Measles (MMR if more than 12 months)
DTwP1/DTaP1 (Tdap if 7 years or more)
OPV1/IPV1 (only if less than 5 years)
Hib 1 (Only if less than 5 years)
Hep B 1
Second visit
(after 1 month of first visit)
BCG (only in less than 5 years)
DTwP2/ DTaP2 (Td if 7 years or more)
OPV 2 (if OPV given earlier)
Hep B 2
Hib 2 (if less than 15 mths
Third visit
(after 1 month of second visit)
OPV3/IPV2
MMR (if more than 12 months)
Typhoid (if more than 2 years)
Fourth visit
(6 months after first visit)
DTwP3/DTaP3 (Td if 7 years or more)
OPV4/IPVB1
HepB3
37. Doâs and Don'ts After Vaccine Administration
⢠Do not rub the site vigorously.
⢠Gentle pressure at the site for a few seconds will
suffice.
⢠If blood oozes do not blot. Just apply gentle pressure
with cotton swab.
⢠No Heat, Ice or Cold Water fomentation is advocated.
⢠The wet cloth soaked in ordinary portable water can
be applied at the site of swelling or tenderness for
about 5 â 10 minutes.
⢠Repeat the procedure, if necessary, 3-4 times a day.